Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Bekeken
• 08/09/23
0
0
insluiten
administrator
abonnees
Dr. Prince, Professor, The University of Melbourne and Monash University, talks about the outcomes of the ALCANZA study in CD30-expressing CTCL
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties